STOCK TITAN

Voyager Acquisition Corp. (NASDAQ: VACH) shareholders approve merger; heavy redemptions reported

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
425

Rhea-AI Filing Summary

Voyager Acquisition Corp. held an extraordinary general meeting and its shareholders approved the Business Combination Agreement to effect a multi-step merger with Veraxa Biotech AG and related corporate steps as described in the agreement.

The record date was February 13, 2026; holders representing 21,743,532 Shares (approximately 68.754% of 31,625,000 issued and outstanding Shares) were present in person or by proxy. Shareholders also approved the Initial Merger, an NTA amendment, four non-binding PubCo charter governance proposals, and an adjournment proposal. In connection with the Meeting, holders of 25,217,315 SPAC Class A Ordinary Shares exercised redemption rights; approximately $885,556 will remain in the trust account, subject to further reversal requests.

Positive

  • None.

Negative

  • None.

Insights

Shareholders approved the multi-step merger structure to implement the business combination.

The meeting approved the Business Combination Agreement and the Initial Merger, which describe a sequence of contributions, an initial merger into Merger Sub, transfers through a Contribution Agent, and a subsequent merger between the Company and PubCo. The approvals permit the corporate steps described to proceed.

Timing and closing conditions in the agreement are operative; any qualifying language such as amendments dated October 18, 2025 and February 2, 2026 remain governing. Subsequent filings will show consummation status and any conditions precedent.

Redemptions materially reduced trust account proceeds and leave a small residual balance.

The filing states holders of 25,217,315 Class A Ordinary Shares redeemed for cash, leaving approximately $885,556 in the trust account, subject to reversal requests. This quantifies the public holder opt-outs at closing.

Cash‑flow treatment and use of remaining trust funds are as disclosed in the agreements; closing disclosures and post‑closing statements will show final cash reconciliation.

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): March 12, 2026

 

 

 

VOYAGER ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

 

 

 

Cayman Islands   001-42211   N/A
(State or other jurisdiction
of Incorporation)
  (Commission
File No.)
  (IRS Employer
Identification No.)

 

131 Concord Street, Brooklyn, NY 11201

(Address of principal executive offices and Zip Code)

 

 

 

Registrant’s telephone number, including area code: (347) 720-2907

 

 

 

Not applicable

(Former name or former address, if changed since last report.)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one half of one redeemable warrant   VACHU   The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share   VACH   The Nasdaq Stock Market LLC
Warrants, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, exercisable 30 days after the completion of our initial business combination and will expire five years after the completion of our initial business combination or earlier upon redemption or our liquidation   VACHW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On March 12, 2026, Voyager Acquisition Corp., a Cayman Islands exempted company (“SPAC”) held an extraordinary general meeting of shareholders (the “Meeting”), at which holders of 21,743,532 SPAC Class A ordinary shares, par value $0.0001 per share (“SPAC Class A Ordinary Shares”) and SPAC Class B ordinary shares, par value $0.0001 per share (“SPAC Class B Ordinary Shares” and, collectively with the SPAC Class A Ordinary Shares, the “Shares”), were present in person or by proxy, representing approximately 68.754% of the voting power of the 31,625,000 issued and outstanding Shares entitled to vote at the Meeting as of the close of business on February 13, 2026, which was the record date for the Meeting.

 

At the Meeting, SPAC shareholders approved a proposal to approve by ordinary resolution and adopt the Business Combination Agreement, dated as of April 22, 2025, by and among SPAC, Veraxa Biotech AG (the “Company”), a public limited company organized under the laws of Switzerland, and Oliver Baumann, solely in his capacity as shareholder representative, as amended on October 18, 2025 and as further amended on February 2, 2026 (the “Business Combination Agreement”), and the transactions contemplated therein (the “Business Combination”), pursuant to which (i) Voyager Acquisition Sponsor Holdco LLC (the “Sponsor”) formed Veraxa Biotech Holding AG (“PubCo”), (ii) PubCo formed an exempted company limited by shares incorporated under the laws of the Cayman Islands, to be a direct wholly owned subsidiary of PubCo (“Merger Sub”), (iii) Sponsor shall transfer the PubCo ordinary shares, par value CHF 1/113.25 per share (the “PubCo Ordinary Shares”) to the Contribution Agent, (iv) SPAC shall merge with and into Merger Sub, with Merger Sub as the surviving company in the merger and, after giving effect to clause (v), continuing as a wholly owned subsidiary of PubCo (the “Initial Merger”), (v) the Contribution Agent shall contribute the Merger Sub shares received in the Initial Merger on behalf of the SPAC shareholders to PubCo and an increase to capital contribution reserves, (vi) the Contribution Agent shall transfer the PubCo Ordinary Shares received by Sponsor to the SPAC shareholders, (vii) Merger Sub will distribute its assets to PubCo as a liquidating distribution and, as soon as reasonably possible, Merger Sub shall be dissolved under the laws of the Cayman Islands and will cease to be a wholly owned subsidiary of PubCo, and (viii) as soon as practicable, but not less than twenty-four hours following the completion of the Initial Merger, the Company will merge with and into PubCo, with PubCo as the surviving entity in the merger (the “Business Combination Proposal”).

 

The following is a tabulation of the votes with respect to the Business Combination Proposal, which was approved by SPAC’s shareholders:

 

Share Votes For   Share Votes Against   Share Abstentions
20,453,587   1,289,900   45

 

At the Meeting, SPAC shareholders also approved a proposal to approve by special resolution the Initial Merger and plan of initial merger (the “Initial Merger Proposal”).

 

The following is a tabulation of the votes with respect to the Initial Merger Proposal, which was approved by SPAC’s shareholders:

 

Share Votes For   Share Votes Against   Share Abstentions
20,453,586   1,289,901   45

 

At the Meeting, SPAC shareholders also approved a proposal to consider and vote to approve by special resolution, an amendment to the SPAC amended and restated memorandum of association to remove the limitation that prevents the SPAC from redeeming SPAC Shares sold as part of SPAC’s initial public offering if such redemption would cause the SPAC to have net tangible assets of less than $5,000,001 (the “NTA Amendment Proposal”).

 

1

 

 

The following is a tabulation of the votes with respect to the NTA Amendment Proposal, which was approved by SPAC’s shareholders:

 

Share Votes For   Share Votes Against   Share Abstentions
20,453,587   1,289,900   45

 

At the Meeting, SPAC shareholders also approved four separate proposals to approve, on a non-binding advisory basis, certain governance provisions in the articles of association of PubCo (the “PubCo Charter”) upon completion of the Business Combination, specifically:

 

To consider and vote for the governance provision in the PubCo Charter providing authorized share capital of PubCo to be CHF 1,247,904 divided into 141,325,128 PubCo Ordinary Shares and authorizes the issuance of conditional share capital up to 40,948,029 PubCo Ordinary Shares, which, the board of directors of PubCo is authorized to increase the share capital at any time until December 31, 2030 up to a maximum of 70,662,564 additional PubCo Ordinary Shares, the votes were as follows:

 

Share Votes For   Share Votes Against   Share Abstentions
20,453,586   1,289,901   45

 

To consider and vote for the governance provision in the PubCo Charter providing for PubCo to have only one class of common shares, the votes were as follows:

 

Share Votes For   Share Votes Against   Share Abstentions
20,453,587   1,289,900   45

 

To consider and vote for the governance provision in the PubCo Charter removing any blank check company provisions, the votes were as follows:

 

Share Votes For   Share Votes Against   Share Abstentions
20,453,586   1,289,901   45

 

To consider and vote for the governance provision in the PubCo Charter providing that directors may only be removed by an absolute majority of the PubCo shareholders represented at a meeting of shareholders, the votes were as follows:

 

Share Votes For   Share Votes Against   Share Abstentions
20,453,587   1,289,900   45

 

At the Meeting, SPAC shareholders also approved a proposal to consider and vote upon a proposal to approve the adjournment of the Meeting to a later date or dates in the event that there are insufficient votes for, or otherwise in connection with, the approval of one or more proposals (the “Adjournment Proposal”).

 

The following is a tabulation of the votes with respect to the Adjournment Proposal, which was approved by SPAC’s shareholders:

 

Share Votes For   Share Votes Against   Share Abstentions
20,442,812   1,300,675   45

 

2

 

 

Item 7.01 Regulation FD Disclosure.

 

On March 13, 2026, SPAC issued a press release (the “Press Release”) disclosing the number of redemptions which occurred in connection with the Meeting. For more information, please see Item 8.01 below. A copy of the Press Release is attached as Exhibit 99.1 and is incorporated herein by reference.

 

The information under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into the filings of SPAC under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 8.01 Other Events.

 

Redemptions

 

In connection with the Meeting, SPAC shareholders holding an aggregate of 25,217,315 SPAC Class A Ordinary Shares exercised their right to redeem such shares for a pro rata portion of the funds in the trust account. As a result, approximately $885,556 will remain in SPAC’s trust account, subject to further redemption reversal requests (if any) received and approved by SPAC prior to the closing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

The following exhibit is attached to this Current Report on Form 8-K:

 

Exhibit No.   Exhibit Title or Description
99.1   Press Release dated March 13, 2026.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

3

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VOYAGER ACQUISITION CORP.
   
Dated: March 18, 2026 By: /s/ Adeel Rouf
  Name: Adeel Rouf
  Title: President and Chief Executive Officer

 

4

FAQ

What did VACH shareholders vote to approve at the meeting?

Shareholders approved the Business Combination Agreement, the Initial Merger, an NTA amendment, four non-binding PubCo charter governance provisions, and an adjournment proposal, each by the vote tallies reported at the meeting.

How many shares were present or represented at the VACH meeting?

Holders of 21,743,532 SPAC Shares were present in person or by proxy, representing approximately 68.754% of the 31,625,000 issued and outstanding Shares entitled to vote as of the record date.

How many Class A shares were redeemed in connection with the meeting?

An aggregate of 25,217,315 SPAC Class A Ordinary Shares were redeemed by holders exercising their redemption rights in connection with the meeting, as disclosed in the filing.

How much cash remains in VACH’s trust account after redemptions?

The filing reports approximately $885,556 will remain in the trust account after the redemptions, subject to any further redemption reversal requests received and approved prior to closing.

Were the PubCo governance provisions binding or advisory?

The four governance provisions in the PubCo Charter were approved on a non-binding advisory basis, as stated in the filing; they are advisory determinations to be reflected in PubCo governance upon completion of the Business Combination.
Voyager Acquisition Corp

NASDAQ:VACH

View VACH Stock Overview

VACH Rankings

VACH Latest News

VACH Latest SEC Filings

VACH Stock Data

347.56M
18.05M
Shell Companies
Biological Products, (no Diagnostic Substances)
Link
United States
HOUSTON